A prognostic impact of interleukin 17 (IL-17) as an immune-marker in patients with bladder cancer
FA Mousa, HA Jasim, F Shakir - Archives of Razi Institute, 2022 - pmc.ncbi.nlm.nih.gov
Urinary bladder cancer is a worldwide health issue and the ninth most prevalent cancer
across the globe, accounting for almost two-thirds of all urinary malignancies. Interleukin 17 …
across the globe, accounting for almost two-thirds of all urinary malignancies. Interleukin 17 …
[PDF][PDF] A prognostic impact of interleukin 32 (IL-32) as an immune marker in patients with bladder cancer.
MM ABD, MH ALYASIRI… - Romanian Journal of …, 2024 - rjmp.com.ro
Background. Urinary bladder cancer is a prevalent global health concern. IL-32 is a cytokine
that promotes inflammation and has been shown in multiple studies to suppress the …
that promotes inflammation and has been shown in multiple studies to suppress the …